Filtered By:
Specialty: Pharmaceuticals
Condition: Heart Attack
This page shows you your search results in order of relevance. This is page number 6.
Order by Relevance | Date
Total 165 results found since Jan 2013.
The Onder Law Firm Announces Launch of National AndroGel Testosterone...
National pharmaceutical and product safety law firm offers confidential case review to men who suffered from heart attack or stroke while taking AndroGel or a similar testosterone product.(PRWeb February 25, 2014)Read the full story at http://www.prweb.com/releases/androgel-testosterone/heart-attack-lawsuit/prweb11613646.htm
Source: PRWeb: Medical Pharmaceuticals - February 25, 2014 Category: Pharmaceuticals Source Type: news
Testosterone Replacement Therapy found to be linked to Heart Problems
The Long Island law firm of Rudolph F. X. Migliore, P. C. provides legal advice to those that been treated for low testosterone and suffered a heart attack, stroke, pulmonary embolism or cardiac...(PRWeb February 25, 2014)Read the full story at http://www.prweb.com/releases/2014/02/prweb11606413.htm
Source: PRWeb: Medical Pharmaceuticals - February 25, 2014 Category: Pharmaceuticals Source Type: news
FDA Probes Risks of Testosterone-Boosting Drugs
The FDA said it is investigating the possible increased risk of stroke, heart attack and death in men who are taking testosterone-boosting products for the condition widely called "low-T."
Source: WSJ.com: Health - January 31, 2014 Category: Pharmaceuticals Tags: PAID Source Type: news
Boston Heart Enables Healthcare Providers to Better Identify Near-Term Risk of Heart Attack or Stroke with Launch of an Important Inflammation Marker, Myeloperoxidase (MPO)
A significant addition that complements the company's innovative suite of diagnostics and services, Boston Heart's MPO is easy for clinicians to use and FDA-cleared.
FRAMINGHAM, Mass., March 6, 2014 -- (Healthcare Sales & Marketing Network) -- Boston H... Diagnostics, Cardiology, Product LaunchBoston Heart Diagnostics, myeloperoxidase, MPO test, heart attack
Source: HSMN NewsFeed - March 6, 2014 Category: Pharmaceuticals Source Type: news
FDA Comes Out Against Aspirin To Prevent First Heart Attacks
In the latest development in a long-simmering debate, the FDA has announced that aspirin should not be marketed for the prevention of a first heart attack or stroke in people with no history of cardiovascular disease. The announcement follows FDA's rejection on Friday of Bayer Healthcare's decade-old petition requesting approval of a primary prevention indication.
Source: Forbes.com Healthcare News - May 5, 2014 Category: Pharmaceuticals Authors: Larry Husten Source Type: news
FDA Approves Novel Merck Drug To Prevent Heart Attacks And Strokes
The FDA today approved vorapaxar (Zontivity), Merck's once-troubled platelet receptor antagonist, to reduce the risk of myocardial infarction (heart attack), stroke, cardiovascular death, and revascularization procedures. The drug is approved for use in people with a history of MI or peripheral arterial disease. The approval represents an amazing turnaround for a drug that had experienced nearly as many ups and downs as an amusement park roller coaster.
Source: Forbes.com Healthcare News - May 8, 2014 Category: Pharmaceuticals Authors: Larry Husten Source Type: news
The Berkowitz Law Firm LLC Announces that it is Evaluating Potential...
As the FDA investigates the potential risk of stroke, heart attack and death among men who use testosterone replacement therapy, the Connecticut defective drug lawyers of The Berkowitz Law Firm LLC...(PRWeb May 20, 2014)Read the full story at http://www.prweb.com/releases/testosterone-heart-risk/berkowitz-law-firm/prweb11849309.htm
Source: PRWeb: Medical Pharmaceuticals - May 20, 2014 Category: Pharmaceuticals Source Type: news
Federal Panel Transfers Low Testosterone Lawsuits To District Court In...
Low Testosterone Lawsuits With The Same Allegations Of Men Suffering Heart Attack, Stroke Or Death After Using Testosterone Helps Panel In Its Decision To Consolidate Lawsuits, Reports Alonso Krangle...(PRWeb June 21, 2014)Read the full story at http://www.prweb.com/releases/2014/06/prweb11963031.htm
Source: PRWeb: Medical Pharmaceuticals - June 21, 2014 Category: Pharmaceuticals Source Type: news
Diabetes Care “Bundle” Produces Better Health Outcomes, AJMC Study...
Geisinger Health System’s use of a diabetes care system among high-risk patients produced lower risks of myocardial infarction, stroke and retinopathy over a three-year period, according to a study in...(PRWeb June 27, 2014)Read the full story at http://www.prweb.com/releases/2014/06/prweb11979766.htm
Source: PRWeb: Medical Pharmaceuticals - June 27, 2014 Category: Pharmaceuticals Source Type: news
Medical Myth: All Health Insurance Plans Created Equal
Studies show your choice of health insurance coverage plays a major role in determining whether you'll experience a stroke, die of a heart attack or suffer another serious health condition.
Source: Forbes.com Healthcare News - June 26, 2014 Category: Pharmaceuticals Authors: Robert Pearl, M.D. Source Type: news
As E-Cigarette Poisoning Reports Rise, Bernstein Liebhard LLP Notes...
The Firm is investigating serious health problems that may be related to the use of e-cigarettes, including hospitalizations for nicotine poisoning, heart attack, stroke, pneumonia, congestive heart...(PRWeb August 08, 2014)Read the full story at http://www.prweb.com/releases/e-cigarette-injury/electronic-cigarettes/prweb12082774.htm
Source: PRWeb: Medical Pharmaceuticals - August 8, 2014 Category: Pharmaceuticals Source Type: news
More Study Urged on Testosterone Drugs
A Food and Drug Administration panel recommended that makers of testosterone-replacement drugs study possible increased risks of heart attack and stroke from the hot-selling products.
Source: WSJ.com: Health - September 18, 2014 Category: Pharmaceuticals Tags: PAID Source Type: news
Studies Show Testosterone Users May Face Heart Attack Risk; Attorneys...
Attorney handling testosterone lawsuits for heart attack and stroke allegations have updated their website at AndrogelTestosteroneLawsuitCenter.com; these testosterone attorneys provide no-cost case...(PRWeb December 03, 2014)Read the full story at http://www.prweb.com/releases/androgel-testosterone/heart-attack/prweb12367210.htm
Source: PRWeb: Medical Pharmaceuticals - December 4, 2014 Category: Pharmaceuticals Source Type: news
Testosterone Lawsuit News: MDL Status Conference Scheduled for January
Lawyers at the Onder Law Firm providing no-cost, no-obligation national Androgel testosterone lawsuit case review have updated their website, the Androgel Testosterone Lawsuit Center.(PRWeb December 23, 2014)Read the full story at http://www.prweb.com/releases/testosterone-lawsuit/heart-attack-stroke/prweb12412542.htm
Source: PRWeb: Medical Pharmaceuticals - December 23, 2014 Category: Pharmaceuticals Source Type: news
